HIV & AIDS

HIV 'cure' in infancy, caution experts

AIDS experts cautioned Monday against hype of a cure after doctors in the United States suppressed HIV in a child born with the virus by administering a potent drug cocktail shortly after birth.

Medical research

New breakthrough could help treat muscular dystrophy

A researcher in the Faculty of Medicine & Dentistry at the University of Alberta improved Duchenne muscular dystrophy symptoms in non-human lab models, using a new drug cocktail. The drug combination targets the “hot ...

Oncology & Cancer

Drug cocktail boosts ovarian cancer survival time

A drug cocktail that combines chemotherapy with Avastin was shown to double the amount of time patients lived without progression of ovarian cancer, according to research released Saturday.

HIV & AIDS

FDA panel backs first pill to block HIV infection

The first drug shown to prevent HIV infection won the endorsement of a panel of federal advisers Thursday, clearing the way for a landmark approval in the 30-year fight against the virus that causes AIDS.

Oncology & Cancer

Less-toxic chemo improves outlook for advanced bladder cancer

(Medical Xpress) -- New data from the University of Rochester Medical Center confirms that an easier, two-drug chemotherapy regimen given to bladder cancer patients prior to surgery shrinks locally advanced tumors and completely ...

Diseases, Conditions, Syndromes

Researcher discusses the urgent need for effective Ebola treatments

The current ebolavirus outbreak in central Africa's Democratic Republic of the Congo (DRC) ranks as the second largest and second deadliest in history: more than 600 cases and more than 370 deaths as of January 6, according ...

HIV & AIDS

Gender, race, and HIV therapy: Insights from the GRACE study

Enrollment of women in clinical trials of new anti-HIV drugs is extremely low, representing only about 15% of all treatment-experienced patients. For women of color it is even lower. Why women, and especially women of color, ...

page 2 from 3